berberine has been researched along with 1-methyl-3-isobutylxanthine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gong, Z; Huang, C; Li, Z; Qin, Y; Sheng, X; Zhang, W; Zhang, Y | 1 |
Chen, M; Li, F; Ning, G; Wang, N; Wang, X; Wu, L; Yang, Y; Yuan, G; Zhang, R; Zhou, L | 1 |
2 other study(ies) available for berberine and 1-methyl-3-isobutylxanthine
Article | Year |
---|---|
Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway.
Topics: 1-Methyl-3-isobutylxanthine; 3T3-L1 Cells; Adipocytes; Animals; Berberine; CCAAT-Enhancer-Binding Protein-alpha; CCAAT-Enhancer-Binding Protein-beta; Cell Differentiation; Cell Proliferation; Dexamethasone; Gene Expression Profiling; Insulin; Mice; PPAR alpha; PPAR gamma; Transcription Factors; Transcriptional Activation | 2006 |
Berberine attenuates cAMP-induced lipolysis via reducing the inhibition of phosphodiesterase in 3T3-L1 adipocytes.
Topics: 1-Methyl-3-isobutylxanthine; 3T3-L1 Cells; Adipocytes; AMP-Activated Protein Kinases; Animals; Berberine; Carrier Proteins; Catecholamines; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Hypoglycemic Agents; Lipolysis; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Perilipin-1; Phosphodiesterase Inhibitors; Phosphoproteins; Sterol Esterase | 2011 |